Analyst Ratings for Roivant Sciences (ROIV)
ROIV Rating Summary
ROIV Price Target Summary
- Highest: $55.00 (TD Cowen)
- Lowest: $35.00 (BofA Securities)
- Average: $46.09
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$46.09 (+26.3%)
* Over Last 12-Mos
Rating Score: 8.7 / 10
Percentile Rank: 87%
Avg. $ Target:
$46.09 (+26.3%)
* Over Last 12-Mos
Rating Score: 8.7 / 10
Percentile Rank: 87%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/12/2026 | Wolfe Research | Andy Chen | Downgrade | Peerperform (Outperform) |
N/A (N/A) |
35.44 (36.49) |
2.96% | Details |
| 9/16/2026 | Stifel | Alex Thompson | New Coverage | Buy (N/A) |
51.00 (N/A) |
39.50 (36.49) |
-7.62% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
